- Navigating Your Midlife Crisis: Embracing New Possibilities
- City Raccoons Showing Signs of Domestication
- Mapping the Exposome: Science Broadens Focus to Environmental Disease Triggers
- One Week Less on Social Media Linked to Better Mental Health
- Your Brain Changes in Stages as You Age, Study Finds
- Some Suicide Victims Show No Typical Warning Signs, Study Finds
- ByHeart Formula Faces Lawsuits After Babies Sickened With Botulism
- Switch to Vegan Diet Could Cut Your Greenhouse Gas Emissions in Half
- Regular Bedtime Does Wonders for Blood Pressure
- Dining Alone Could Mean Worse Nutrition for Seniors
Xtoro Approved for Swimmer’s Ear
Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer’s ear, clinically known as acute otitis externa.
The infection of the outer ear and ear canal, most often caused by ear canal bacteria, has typical symptoms including pain, swelling, redness and discharge, the FDA said in a news release.
The drug’s safety and effectiveness were evaluated in a clinical study of more than 1,200 people, aged 6 months to 85 years. The most common side effects were ear itching and nausea.
Xtoro is produced by Alcon Laboratories, based in Fort Worth, Texas.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.
Related
-
Navigating Your Midlife Crisis: Embracing New PossibilitiesA midlife crisis can open doors to personal growth...
- December 4, 2025
-
Want A Happier Hospital? Hire More Nurses, Study SaysAdding even a few extra nurses can dramatically reduce...
- November 20, 2025
-
Plasma Treatment Shows Promise For Menopause Symptoms Among Breast Cancer SurvivorsPlasma infusions may help breast cancer survivors avoid genital...
- November 20, 2025
-
Self-Hypnosis Can Thwart Hot FlashesSelf-hypnosis might help some women in menopause find relief...
- November 14, 2025
